Literature DB >> 17114823

Defects of immune regulation in the presenilin-1 mutant knockin mouse.

Grant A Morgan1, Qing Guo, Sic L Chan, Devin S Gary, Barbara A Osborne, Mark P Mattson.   

Abstract

Mutations in the presenilin-1 (PS1) gene are causally linked to early-onset Alzheimer's disease (AD). Studies of neurons suggest that PS1 mutations result in a gain-of-function, which perturbs calcium regulation and increases cell vulnerability to apoptosis. Alterations in immune cell function have also been demonstrated in AD, and a role for PS1 in immune regulation has been suggested recently. We now report that splenocytes from PS1-mutant (M146V) knockin mice exhibit increased caspase activity, abnormal calcium regulation and aberrant mitochondrial function. Isolated splenic T cells from PS1-mutant mice respond poorly to proliferative signals and have downregulated cluster designation 3 and interleukin (IL)- 2-receptor expression necessary for a normal T-cell immune response. Thus, adverse effects of a mutation that causes AD on immune function that involves perturbed calcium regulation and cytokine signaling in lymphocytes, and associated sensitivity of lymphocytes to apoptosis are demonstrated. These findings suggest that abnormalities in immune function might play major roles in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17114823     DOI: 10.1385/nmm:9:1:35

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  42 in total

1.  The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia.

Authors:  J Sulger; C Dumais-Huber; R Zerfass; F A Henn; J B Aldenhoff
Journal:  Biol Psychiatry       Date:  1999-03-15       Impact factor: 13.382

Review 2.  Mitochondria: releasing power for life and unleashing the machineries of death.

Authors:  Donald D Newmeyer; Shelagh Ferguson-Miller
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

Review 3.  Notch and the immune system.

Authors:  Ivan Maillard; Scott H Adler; Warren S Pear
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

4.  Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered.

Authors:  A Eckert; C W Cotman; R Zerfass; M Hennerici; W E Müller
Journal:  J Neural Transm Suppl       Date:  1998

5.  Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

Authors:  K Duff; C Eckman; C Zehr; X Yu; C M Prada; J Perez-tur; M Hutton; L Buee; Y Harigaya; D Yager; D Morgan; M N Gordon; L Holcomb; L Refolo; B Zenk; J Hardy; S Younkin
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

6.  Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease.

Authors:  J T Stieler; C Lederer; M K Brückner; H Wolf; M Holzer; H J Gertz; T Arendt
Journal:  Neuroreport       Date:  2001-12-21       Impact factor: 1.837

7.  Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease.

Authors:  S L Chan; W S Griffin; M P Mattson
Journal:  J Neurosci Res       Date:  1999-08-01       Impact factor: 4.164

Review 8.  Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.

Authors:  C Pereira; P Agostinho; P I Moreira; S M Cardoso; C R Oliveira
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-08

Review 9.  Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease.

Authors:  M Popović; M Caballero-Bleda; L Puelles; N Popović
Journal:  Int J Neurosci       Date:  1998-09       Impact factor: 2.292

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  5 in total

Review 1.  Implications of non-canonical G-protein signaling for the immune system.

Authors:  Cédric Boularan; John H Kehrl
Journal:  Cell Signal       Date:  2014-02-28       Impact factor: 4.315

2.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

Review 3.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

Review 4.  Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?

Authors:  Bo Su; Xinglong Wang; David Bonda; Gorge Perry; Mark Smith; Xiongwei Zhu
Journal:  Mol Neurobiol       Date:  2010-01-27       Impact factor: 5.590

5.  Exercise and early-onset Alzheimer's disease: theoretical considerations.

Authors:  Astrid M Hooghiemstra; Laura H P Eggermont; Philip Scheltens; Wiesje M van der Flier; Erik J A Scherder
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.